Murphy & Mullick Capital Management Corp Invests $711,000 in UnitedHealth Group Incorporated (NYSE:UNH)

Murphy & Mullick Capital Management Corp acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 1,406 shares of the healthcare conglomerate’s stock, valued at approximately $711,000.

Other hedge funds have also recently modified their holdings of the company. Howard Capital Management Group LLC bought a new stake in UnitedHealth Group during the 3rd quarter valued at about $341,000. Principal Financial Group Inc. boosted its holdings in shares of UnitedHealth Group by 11.3% in the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock valued at $1,039,933,000 after purchasing an additional 180,479 shares during the period. Algert Global LLC purchased a new position in UnitedHealth Group during the 3rd quarter worth $1,763,000. Truvestments Capital LLC lifted its holdings in shares of UnitedHealth Group by 13.0% in the 3rd quarter. Truvestments Capital LLC now owns 591 shares of the healthcare conglomerate’s stock worth $346,000 after buying an additional 68 shares during the period. Finally, Mirabella Financial Services LLP purchased a new position in shares of UnitedHealth Group during the third quarter valued at $235,000. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of several recent research reports. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Stephens upped their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Oppenheimer lifted their target price on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Finally, Barclays cut their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average target price of $629.32.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Stock Performance

UNH opened at $513.58 on Wednesday. The firm has a 50 day moving average of $509.10 and a two-hundred day moving average of $545.56. The firm has a market capitalization of $469.78 billion, a PE ratio of 33.13, a P/E/G ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period last year, the firm earned $5.83 EPS. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.64%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.